CRAI, US12563P1057

CRA International stock (US12563P1057): Insider sale puts focus on consulting specialist

21.05.2026 - 07:22:34 | ad-hoc-news.de

An insider sale by a top executive and the upcoming first?quarter 2026 earnings call are drawing fresh attention to CRA International’s Nasdaq?listed stock. What the transaction means and how the consulting firm makes its money.

CRAI, US12563P1057
CRAI, US12563P1057

An insider share sale at CRA International is drawing attention to the Nasdaq?listed consulting specialist just ahead of its next earnings update. According to a Form 4 filing summarized by MT Newswires on May 20, 2026, executive vice president and general counsel Jonathan D. Yellin sold 2,250 shares of company stock on May 19, 2026, in open?market transactions, with an aggregate value of about 332,000 US dollars, as reported by MarketScreener as of 05/20/2026 and based on SEC disclosures referenced by Stock Titan as of 05/20/2026.

The sale comes shortly before CRA International’s next scheduled financial update. The company announced that it will host its first?quarter fiscal 2026 earnings conference call and webcast on May 7, 2026, offering investors fresh insight into trading conditions and demand across its consulting practices, according to an event notice carried by Stock Titan as of 04/15/2026.

As of: 21.05.2026

By the editorial team – specialized in equity coverage.

At a glance

  • Name: CRA International
  • Sector/industry: Consulting and business services
  • Headquarters/country: Boston, United States
  • Core markets: North America, Europe and selected global markets
  • Key revenue drivers: Economic, financial and management consulting mandates
  • Home exchange/listing venue: Nasdaq (ticker: CRAI)
  • Trading currency: US dollar (USD)

CRA International: core business model

CRA International, which also markets itself under the Charles River Associates brand, is a specialized consulting firm focused on economic, financial and management advisory services. Its experts typically work with corporations, law firms, regulatory bodies and government agencies on complex, data?driven projects. According to the company’s profile information and investor materials made available on its website, CRA’s assignments often involve rigorous quantitative analysis and expert testimony in high?stakes environments.

The firm’s business model is largely project?based. Clients engage CRA International when they need independent economic or financial expertise, such as in merger reviews, antitrust and competition investigations, securities litigation, intellectual property disputes or regulatory policy assessments. Engagements can range from short advisory tasks to multi?year mandates linked to litigation or regulatory processes, and fee structures often combine hourly billing rates with project?specific pricing components. This setup means utilization and pricing discipline are central to profitability.

Beyond litigation support, CRA International provides management consulting focused on strategy, performance improvement and industry?specific analytics. These services are particularly relevant in data?intensive industries like energy, telecommunications, financial services and life sciences. The company’s teams use economic modeling, advanced statistics and sector expertise to help clients assess market dynamics, design pricing strategies, evaluate investment decisions and respond to regulatory change. This mix of litigation?driven and advisory work can help smooth revenue over time, though individual cases may still have sizable impact on quarterly figures.

A key part of CRA International’s value proposition is the depth of its expert network. Many of its consultants and affiliated experts hold advanced degrees in economics, finance or related disciplines. Their reputations can be critical for winning mandates, especially when testimony in court or before regulators is required. Over time, the firm has built recognized practices in areas such as antitrust and competition economics, transfer pricing, finance and securities, energy, and life sciences. This specialization can support pricing power but also exposes the company to swings in demand when particular segments, such as M&A or capital markets, slow down.

From an operational standpoint, CRA International’s cost base is heavily driven by compensation and benefits for professional staff, along with real estate and technology expenses required to support global teams. Managing utilization rates – the share of billable hours relative to total staff time – is therefore critical. When demand is strong and teams are fully utilized, the incremental margin on additional revenue can be attractive. Conversely, weaker project pipelines or delays in case timelines can pressure margins because a significant portion of costs are relatively fixed in the short term.

For US investors, CRA International represents a niche play on demand for high?end consulting and expert services, particularly within the US legal and regulatory system. Because many of the world’s largest capital markets, law firms and regulatory agencies are US?based, the firm’s Boston headquarters and Nasdaq listing position it close to key clients and decision?makers. At the same time, its international footprint means it can participate in cross?border cases and policy debates, providing some diversification beyond the domestic cycle.

Main revenue and product drivers for CRA International

CRA International’s revenue is generated across a portfolio of consulting practices, each tied to specific industry verticals or service types. While the company’s exact segment reporting can evolve over time, its core drivers include antitrust and competition economics, finance and securities consulting, energy and industrials advisory, and life sciences work. In antitrust and competition, CRA is engaged by companies and law firms involved in merger reviews, cartel investigations and abuse?of?dominance cases. These matters often require detailed modeling of market structures, pricing effects and consumer welfare, and can last for months or even years as proceedings move through regulatory and judicial channels.

Finance and securities work is another important contributor. Here, CRA International’s experts may analyze alleged market manipulation, insider trading claims, valuation disputes or questions around structured products and derivatives. Assignments can involve reconstructing complex trading strategies, evaluating risk?management systems or determining the economic impact of alleged misconduct. Because these topics are deeply connected to the functioning of US capital markets, demand can be influenced by enforcement activity from regulators and by the volume of securities litigation more broadly.

In energy and industrials, CRA International helps companies and regulators assess market design, pricing mechanisms and the impact of policy changes. For example, consulting assignments might focus on electricity market reforms, renewable?energy integration, gas pricing frameworks or infrastructure investment decisions. As the global energy system transitions toward lower?carbon sources, demand for sophisticated modeling of supply?demand scenarios, carbon pricing and grid reliability is likely to remain substantial. This creates opportunities for specialized advisory firms that can combine economic theory with practical industry knowledge.

The life sciences and healthcare segment typically involves work with pharmaceutical manufacturers, biotech companies and healthcare providers. CRA consultants may support clients with pricing and market access strategies, health economics and outcomes research, or the economic evaluation of clinical trial results. In heavily regulated markets, where reimbursement decisions by public and private payers directly influence commercial success, rigorous health?economic analysis is crucial. The company’s ability to translate statistical evidence into policy?relevant conclusions can be a differentiator in winning such mandates.

Beyond these core areas, CRA International also provides general management consulting services, such as corporate strategy, organizational design and performance improvement. While this work may not always attract the same level of public attention as high?profile litigation cases, it can help diversify the revenue base and deepen long?term client relationships. Multi?year strategy engagements or recurring advisory roles can provide more visibility and stability compared with case?driven assignments that depend on litigation timelines.

From a financial perspective, revenue growth is closely tied to the firm’s ability to recruit and retain qualified experts, expand its practice areas and secure repeat mandates from existing clients. Utilization rates, average billing rates and the mix between senior and junior staff hours all influence profitability. When the company successfully leverages its expert network across multiple geographies and industries, operating leverage can enhance margins. Conversely, any slowdown in demand, heightened pricing pressure or difficulty in attracting talent can weigh on results.

Investors also watch the firm’s backlog and pipeline indicators, where disclosed, to gauge near?term revenue visibility. Large, multi?year matters can provide a revenue foundation, but individual case outcomes or settlements may affect the duration and intensity of consulting work. As a result, quarterly revenue and earnings can be somewhat volatile, even if the broader trend is positive. This dynamic is typical for specialized consulting and advisory businesses that rely on a relatively concentrated set of high?value engagements.

Official source

For first-hand information on CRA International, visit the company’s official website.

Go to the official website

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Conclusion

The recent insider share sale by a senior executive at CRA International, disclosed through a Form 4 filing and reported by financial news services in late May 2026, has put a spotlight on the company’s stock just as it approaches its first?quarter 2026 earnings call. While insider transactions can attract attention, they may occur for a range of reasons that are not necessarily linked to the firm’s operating outlook. For US investors, the more structural story remains tied to CRA International’s role as a specialized provider of economic, financial and management consulting services, its exposure to litigation and regulatory cycles, and its ability to maintain utilization and pricing power across key practices. The company’s Nasdaq listing, US headquarters and international footprint make it a focused way to gain exposure to high?end consulting demand, but also mean results can be influenced by shifts in legal activity, regulatory priorities and the broader macro environment.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

So schätzen die Börsenprofis CRAI Aktien ein!

<b>So schätzen die Börsenprofis CRAI Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | US12563P1057 | CRAI | boerse | 69388140 | bgmi